❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Immunology ❭

Department of Immunology

Head of department: John Torgils Vaage
Head of research: Ludvig A. Munthe

Research groups:

Adaptive Immunity and Homeostasis

Jan Terje Andersen

Molecular immunology and vaccine development

Ranveig Braathen

Norwegian Center for Stem Cell Research

Joel Glover
Director NCS
 

Computational and Systems Immunology

Victor Greiff

Influenza and Adaptive Immunity

Gunnveig Grødeland

Autoimmunity and B-cell biology

Rasmus Iversen

Laboratory of Immunoregulation and T Cell Biology 

Johanne Tracey Jacobsen

 Cell Signalling Research Group 

Stefan Krauss

Protein Array Group 

Fritdjof Lund-Johansen

The Complement Research Group 

T. E. Mollnes

Blood and Lymphoproliferative Diseases 

Ludvig A. Munthe

Blood donation, transfusion and immunomodulation 

Lise Sofie Haug Nissen-Meyer

Cell Signalling Networks in Innate Immunity 

Tuula Anneli Nyman

Molecular Immunology by Receptor and Transcriptomics Analysis 

Shuo-Wang Qiao

Functional Immunogenetics 

Ludvig Sollid

B-Cell Receptor signaling Group 

Peter Szodoray

Cell Signaling and Drug Discovery

Jo Waaler

 

 
Scroll to top

Home Laboratory Medicine Dept. of Immunology

  • Adaptive Immunity and Homeostasis (Andersen)
  • Molecular immunology and vaccine development (Braathen)
  • Norwegian Center for Stem Cell Research (Glover)
  • Computational and Systems Immunology (Greiff)
  • Influenza and Adaptive Immunity (Grødeland)
  • Autoimmunity and B-cell biology
  • Laboratory of Immunoregulation and T Cell Biology (J.T. Jacobsen)
  • Cell Signalling Research Group (Krauss)
  • Protein Array Group (Lund-Johansen)
  • Complement (Mollnes)
  • Blood and Lymphoproliferative Diseases (Munthe)
  • Blood donation, transfusion and immunomodulation (Nissen-Meyer)
  • Cell Signalling Networks in Activation of Innate Immunity (Nyman)
  • Molecular Immunology by Receptor and Transcriptomics Analysis (Qiao)
  • Functional Immunogenetics (Sollid)
  • B-Cell Receptor signaling Group (Szodoray)
  • Cell Signaling and Drug Discovery (Waaler)
  • IMMI Staff
  • Publications, annual summary

Recent publications

Wikan VE, Øverli Ø, Ueland T, Mollnes TE, Brækkan SK, Michelsen AE, Yeganeh GJ, Hansen JB, Brodin EE (2025)
Complement activation assessed by C3bc and C5b-9 terminal complex as diagnostic biomarkers for deep vein thrombosis
PLoS One, 20 (10), e0333206
DOI 10.1371/journal.pone.0333206, PubMed 41052133

Saber SH, Yak N, Yong XLH, Bong YT, Leeson H, Dai CY, Binder T, Lu S, Purushothaman R, Lenaerts AS, Almeida-Souza L, Koludarova L, Er S, Hlushchuk I, Gaudin A, Singh S, Nyman TA, Harmer JR, Zuryn S, Wolvetang E, Talbo GH, Airavaara M, Battersby BJ, van Waardenberg AJ, Anggono V et al. (2025)
DDHD2 provides a flux of saturated fatty acids for neuronal energy and function
Nat Metab (in press)
DOI 10.1038/s42255-025-01367-x, PubMed 41028912

Aaen KH, Testa MF, Nilsen J, Tarantino R, Canepari C, Benedusi M, Benjakul S, Nyquist-Andersen M, Herigstad ML, Cantore A, Valacchi G, Sandlie I, Bernardi F, Pinotti M, Branchini A, Andersen JT (2025)
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
Nat Commun, 16 (1), 8433
DOI 10.1038/s41467-025-62955-9, PubMed 41022699

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)